MY192867A - Orally disintigrating tablet comprising moringa oleifera leaves powder - Google Patents

Orally disintigrating tablet comprising moringa oleifera leaves powder

Info

Publication number
MY192867A
MY192867A MYPI2017701083A MYPI2017701083A MY192867A MY 192867 A MY192867 A MY 192867A MY PI2017701083 A MYPI2017701083 A MY PI2017701083A MY PI2017701083 A MYPI2017701083 A MY PI2017701083A MY 192867 A MY192867 A MY 192867A
Authority
MY
Malaysia
Prior art keywords
tablet
orally
disintigrating
moringa oleifera
leaves powder
Prior art date
Application number
MYPI2017701083A
Inventor
Aniza Yusof Yus
Nyuk Ling Chin
Nordin Ibrahim Mohd
Azhar Ali Muhammad
Original Assignee
Univ Putra Malaysia Upm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Putra Malaysia Upm filed Critical Univ Putra Malaysia Upm
Priority to MYPI2017701083A priority Critical patent/MY192867A/en
Publication of MY192867A publication Critical patent/MY192867A/en

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention provides an orally disintegrating tablet comprising Moringa oleifera leaves powder as a pharmaceutically active ingredient and fruit powder as a superdisintegrant. The tablet of the invention can be used as a dietary supplement as it contains many vitamins and therefore is also applicable in the treatment of vitamin deficiency.
MYPI2017701083A 2017-03-28 2017-03-28 Orally disintigrating tablet comprising moringa oleifera leaves powder MY192867A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2017701083A MY192867A (en) 2017-03-28 2017-03-28 Orally disintigrating tablet comprising moringa oleifera leaves powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2017701083A MY192867A (en) 2017-03-28 2017-03-28 Orally disintigrating tablet comprising moringa oleifera leaves powder

Publications (1)

Publication Number Publication Date
MY192867A true MY192867A (en) 2022-09-13

Family

ID=83444714

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017701083A MY192867A (en) 2017-03-28 2017-03-28 Orally disintigrating tablet comprising moringa oleifera leaves powder

Country Status (1)

Country Link
MY (1) MY192867A (en)

Similar Documents

Publication Publication Date Title
PH12018502251A1 (en) Formulations of an lsd1 inhibitor
WO2016172657A3 (en) Glycan therapeutics and methods of treatment
SA517381819B1 (en) Immune modulation
WO2016190683A8 (en) Composition for preventing and treating muscle diseases or improving muscular function, containing platycodon grandiflorum extract
EP3873442A4 (en) Administration of butyrate, bete-hydroxybutyrate, cannabidiol, and related compounds in humans
PH12020550815A1 (en) Delayed release deferiprone tablets and methods of using the same
NZ745186A (en) 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2018000262A (en) Therapeutic uses of berberine formulations.
IL250418A0 (en) Use in one pill / tablet / capsule minocycline, acicloguanosin, atorvastatin and vitamin d in the treatment of rheumatoid arthritis
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
PH12017500743A1 (en) Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
MY192867A (en) Orally disintigrating tablet comprising moringa oleifera leaves powder
WO2019151964A3 (en) Orally disintegrating formulations of saxagliptin
MX2019013683A (en) A pharmaceutical combination for the treatment of a cancer.
PH12020500606A1 (en) Use of functionalized calcium carbonate as active ingredient
EP3893914A4 (en) Maleate of scy-635 and uses thereof in medicine
MX2020005682A (en) Extract of helichrysum gymnocephalum for the treatment and/or prevention of inflammatory dermatoses.
PT3511001T (en) Pirfenidone-containing tablet and capsule formulation
NZ739679A (en) Cholecalciferol sulfate salts and their use for the treatment of vitamin d deficiency
WO2015126151A3 (en) Composition for wound healing comprising massa medicata fermentata extract
PL423329A1 (en) Application of Kamchatka berry Lonicera caerulea L. var. Kamtschatica or its tissue or the products thereof, preferably the fruit extract
ZA202104321B (en) Aqueous paediatric retinol formulations
EP4074828A4 (en) Uses of cyp4v2 and rdcvf in preparation of drugs
PH12020550456A1 (en) Alcohol-resistant oral pharmaceutical compositions of lorazepam